Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of HSK31858 tablets in patients with airway mucus hypersecretion; the trial is currently enrolling by invitatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchiectasis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• HSK31858 (HSK31858)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Asthma Bronchiale, Bronchiectasis | Phase 2 | Status: ENROLLING_BY_INVITATION